These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 157805)

  • 21. Enzymatic conversion of 5-fluoro-2'-deoxyuridine to 5-fluorouracil or 5-fluoro-2'-deoxyuridine 5'-monophosphate in human tissues.
    Uchida M; Brown N; Ho DH
    Anticancer Res; 1990; 10(3):779-83. PubMed ID: 2142396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role for cytosolic folate-binding proteins in the compartmentation of endogenous tetrahydrofolates and the 5-formyl tetrahydrofolate-mediated enhancement of 5-fluoro-2'-deoxyuridine antitumor activity in vitro.
    Matherly LH; Czajkowski CA; Muench SP; Psiakis JT
    Cancer Res; 1990 Jun; 50(11):3262-9. PubMed ID: 2139802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.
    Berger SH; Hakala MT
    Mol Pharmacol; 1984 Mar; 25(2):303-9. PubMed ID: 6608049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line.
    Grem JL; Mulcahy RT; Miller EM; Allegra CJ; Fischer PH
    Biochem Pharmacol; 1989 Jan; 38(1):51-9. PubMed ID: 2462882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selectivity of action of 5-FU: biochemical basis.
    Rustum YM; Danhauser L; Wang G
    Bull Cancer; 1979; 66(1):43-7. PubMed ID: 154352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the rational development of a new drug: the example of the fluorinated pyrimidines.
    Heidelberger C
    Cancer Treat Rep; 1981; 65 Suppl 3():3-9. PubMed ID: 7346154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic channeling of 5-fluoro-2'-deoxycytidine utilizing inhibitors of its deamination in cell culture.
    Boothman DA; Briggle TV; Greer S
    Mol Pharmacol; 1985 May; 27(5):584-94. PubMed ID: 2581125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A nitrocellulose-filter assay for the binary complex of 5-fluorodeoxyuridylate and Lactobacillus casei thymidylate synthetase.
    Ahmed F; Moore MA; Dunlap RB
    Anal Biochem; 1985 Feb; 145(1):151-9. PubMed ID: 3923859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A method for the determination of total, free, and 5-fluorodeoxyuridylate-bound thymidylate synthase in cell extracts.
    Fernandes DJ; Cranford SK
    Anal Biochem; 1984 Nov; 142(2):378-85. PubMed ID: 6241433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 5-fluorouracil metabolism in two human gastrointestinal tumor cell lines.
    Washtien WL
    Cancer Res; 1984 Mar; 44(3):909-14. PubMed ID: 6318987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and quantitation of 5-fluorouridine in rat urine after administration of 5-fluorouracil or 5-fluoro-2'-deoxyuridine.
    Gelijkens CF; Sandra P; Belpaire F; De Leenheer AP
    Drug Metab Dispos; 1980; 8(5):363-6. PubMed ID: 6107236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance of CCRF-CEM cloned sublines to 5-fluorodeoxyuridine associated with enhanced phosphatase activities.
    Fernandes DJ; Cranford SK
    Biochem Pharmacol; 1985 Jan; 34(1):125-32. PubMed ID: 3155614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
    van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
    Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
    Ingraham HA; Tseng BY; Goulian M
    Mol Pharmacol; 1982 Jan; 21(1):211-6. PubMed ID: 6215571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.
    Sommadossi JP; Gewirtz DA; Cross DS; Goldman ID; Cano JP; Diasio RB
    Cancer Res; 1985 Jan; 45(1):116-21. PubMed ID: 3965128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of 5-fluorouracil sensitivity in human tumors.
    Moran RG; Heidelberger C
    Bull Cancer; 1979; 66(1):79-83. PubMed ID: 420950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
    Spears CP; Shani J; Shahinian AH; Wolf W; Heidelberger C; Danenberg PV
    Mol Pharmacol; 1985 Feb; 27(2):302-7. PubMed ID: 2578605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of response to antimetabolites and their modulation by normal purine and pyrimidine metabolites.
    Rustum YM; Danhauser L; Luccioni C; Au JL
    Cancer Treat Rep; 1981; 65 Suppl 3():73-82. PubMed ID: 7049369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
    Chu E; Zinn S; Boarman D; Allegra CJ
    Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.